carcinolipin

cholesterol, 14-methylhexadecanoate

CAS: 19477-24-8 C44 H78 O2 MW: 639.10406000

Identification

Namecarcinolipin
IUPAC[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 14-methylhexadecanoate
CAS Number19477-24-8
FDA UNIISearch
Molecular FormulaC44 H78 O2
Molecular Weight639.10406000
Beilstein2493354

Regulatory

Physical Properties

Assay 95.00 to 100.00
Food Chemicals Codex Listed No
Boiling Point 658.86 °C. @ 760.00 mm Hg (est)
Flash Point 666.00 °F. TCC ( 352.50 °C. ) (est)
logP (o/w) 18.028 (est)
Soluble in water, 2.508e-013 mg/L @ 25 °C (est)

No sensory data available

Safety Information

Oral/Parenteral ToxicityNot determined
Dermal ToxicityNot determined
Inhalation ToxicityNot determined

GHS Classification

['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']

Safety in Use

Categorynatural substances and extractives
Recommendation for carcinolipin usage levels up tonot for fragrance use.
Recommendation for carcinolipin flavor usage levels up tonot for flavor use.

No supplier data available

Potential Uses

None Found

Natural Occurrence

found in nature

Synonyms

cholest-5-en-3-yl 14-methylhexadecanoate cholest-5-en-3beta-ol-14-methyl hexadecanoate cholesterol, 14-methylhexadecanoate cholesteryl 14-methyl palmitate cholesteryl 14-methylpalmitate cholesteryl-14-methyl hexadecanoate [10,13- dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 14-methylhexadecanoate 3-b-14- methylhexadecanoate-cholest-5-en-3-ol PubMed: Determination of cholesteryl 14-methylhexadecanoate in blood serum by reversed-phase high-performance liquid chromatography. PubMed: Stimulating effect of blood serums from tumor-bearing rats on cholesteryl ester synthesis in normal rat liver cytosol in vitro. PubMed: The role of cholesteryl 14-methylhexadecanoate in the function of eukaryotic peptide elongation factor 1. PubMed: Enhanced utilization of 14-methylhexadecanoic acid for the synthesis of lipids during the growth of Walker 256 carcinoma in rats. PubMed: [Transplacental action of carcinolipin]. PubMed: Transplacental effect of carcinolipin in mice. PubMed: The chemical constitution of carcinolipin. PubMed: Purification of the fatty acid present in carcinolipin. PubMed: A chromatographic method for the quantitative determination of cholesterol 14-methylhexadecanoate (carcinolipin) in biological materials. PubMed: Isolation of carcinolipin by combined liquid-solid and liquid-liquid chromatography. PubMed: Effect of carcinolipin on the adenosine triphosphatase activity of isolated cellular fractions. PubMed: CARCINOLIPIN--AN ESSENTIAL FACTOR IN PROTEIN SYNTHESIS. PubMed: LIVER CHANGES CAUSED BY CARCINOLIPIN. PubMed: Effect of carcinolipin on protein synthesis in cell-free systems. PubMed: Carcinolipin: an endogenous carcinogenic substance.